HAP Trading’s Teladoc Health TDOC Stock Holding History

HAP Trading’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,500	Closed	-$41.4K	–	1185
2023 Q3	$41.4K	Buy	+14,500	New	+$338K	0.01%	540
2022 Q4	–	Sell	-248,759	Closed	-$2.72M	–	1865
2022 Q3	$2.72M	Buy	248,759 +25,382	+11%	+$890K	0.18%	122
2022 Q2	$2.1M	Buy	223,377 +192,100	+614%	+$8.16M	0.11%	167
2022 Q1	$822K	Sell	31,277 -94,777	-75%	-$6.83M	0.03%	396
2021 Q4	$1.94M	Buy	126,054 +75,300	+148%	+$9M	0.05%	315
2021 Q3	$1.67M	Sell	50,754 -11,000	-18%	-$1.6M	0.05%	317
2021 Q2	$1.23M	Buy	+61,754	New	+$10M	0.04%	392
2021 Q1	–	Sell	-59,744	Closed	-$674K	–	2345
2020 Q4	$674K	Buy	+59,744	New	+$12.1M	0.02%	532
2020 Q3	–	Sell	-24,500	Closed	-$123K	–	1876
2020 Q2	$123K	Buy	+24,500	New	+$4.29M	0.01%	806

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HAP Trading's TDOC Position: Q4 2022 in Review

HAP Trading sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 139,962 shares — an estimated $3.77M sold.

HAP Trading first reported a position in TDOC in Q3 2018 and held it in 8 quarters. The position peaked at $8.74M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

HAP Trading reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
HAP Trading sold 139,962 Teladoc Health shares in Q4 2022, an estimated $3.77M.
HAP Trading first reported a position in Teladoc Health in Q3 2018 and held it in 8 quarters.
HAP Trading's Teladoc Health position peaked at $8.74M in Q4 2020.
443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on HAP Trading's 13F filing for Q4 2022, filed 14 Feb 2023.